Literature DB >> 34591655

Neoadjuvant Docetaxel, Oxaliplatin, and S-1 in Resectable Advanced Gastric Cancer.

Dun-Chang Mo1, Lang Qin1, Lin-Jing Ye1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34591655     DOI: 10.1200/JCO.21.01528

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  2 in total

Review 1.  Donafenib: First Approval.

Authors:  Susan J Keam; Sean Duggan
Journal:  Drugs       Date:  2021-11       Impact factor: 9.546

Review 2.  Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy.

Authors:  Wenhao Liao; Yuchen Li; Jing Wang; Maoyuan Zhao; Nianzhi Chen; Qiao Zheng; Lina Wan; Yu Mou; Jianyuan Tang; Zhilei Wang
Journal:  Int J Nanomedicine       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.